[1] Fu WB, Pang LJ, Chen YZ, Yang L, Zhu JB, Wei YT. The microRNAs as prognostic biomarkers for survival in esophageal cancer: a meta-analysis. Scientific World J , 2014, 2014: 523979. [2] Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. Ca Cancer J Clin , 2011, 61(2): 69-90. [3] Hong L, Han Y, Zhang HW, Zhao QC, Wu KC, Fan DM. Prognosis-related microRNAs in esophageal cancer. Expert Opin Biol Ther , 2014, 14(4): 483-489. [4] Zhou SL, Wang LD. Circulating microRNAs: novel biomarkers for esophageal cancer. World J Gastroenterol , 2010, 16(19): 2348-2354. [5] Zhang C, Xue GL, Bi JW, Geng M, Chu HL, Guan YP, Wang J, Wang BC. Cytoplasmic expression of the ELAV-like protein HuR as a potential prognostic marker in esophageal squamous cell carcinoma. Tumor Biol , 2014, 35(1): 73-80. [6] Zhang CN, Wang C, Chen X, Yang CH, Li K, Wang JJ, Dai JC, Hu ZB, Zhou XJ, Chen LB, Zhang YN, Li YF, Qiu H, Xing JC, Liang ZC, Ren BH, Yang C, Zen K, Zhang CY. Expression profile of microRNAs in serum: a fingerprint for esophageal squamous cell carcinoma. Clin Chem , 2010, 56(12): 1871-1879. [7] Komatsu S, Ichikawa D, Takeshita H, Tsujiura M, Morimura R, Nagata H, Kosuga T, Iitaka D, Konishi H, Shiozaki A, Fujiwara H, Okamoto K, Otsuji E. Circulating microRNAs in plasma of patients with oesophageal squamous cell carcinoma. Br J Cancer , 2011, 105(1): 104-111. [8] Tanaka K, Yano M, Motoori M, Kishi K, Miyashiro I, Shingai T, Gotoh K, Noura S, Takahashi H, Ohue M, Yamada T, Ohigashi H, Yamamoto T, Yamasaki T, Doki Y, Ishikawa O. CEA-antigen and SCC-antigen mRNA expression in peripheral blood predict hematogenous recurrence after resection in patients with esophageal cancer. Ann Surg Oncol , 2010, 17(10): 2779-2786. [9] 蔡晓波, 李庆, 郭俊明, 徐进, 季林丹. MicroRNA与食管癌的研究进展. 中国细胞生物学学报, 2013, 35(9): 1405-1411. [10] Wu CH, Li MJ, Hu C, Duan HB. Clinical significance of serum miR-223, miR-25 and miR-375 in patients with esophageal squamous cell carcinoma. Mol Biol Rep , 2014, 41(3): 1257-1266. [11] Song YM, Li L, Ou YW, Gao ZB, Li EM, Li XC, Zhang WM, Wang JQ, Xu LY, Zhou Y, Ma XJ, Liu LY, Zhao ZT, Huang XL, Fan J, Dong LJ, Chen G, Ma LY, Yang J, Chen LY, He MH, Li M, Zhuang XH, Huang K, Qiu KL, Yin GL, Guo GW, Feng Q, Chen PS, Wu ZY, Wu JY, Ma L, Zhao JY, Luo LH, Fu M, Xu BN, Chen B, Li YR, Tong T, Wang MR, Liu ZH, Lin DX, Zhang XQ, Yang HM, Wang J, Zhan QM. Identification of genomic alterations in oesophageal squamous cell cancer. Nature , 2014, 509(7498): 91-95. [12] Finnegan EF, Pasquinelli AE. MicroRNA biogenesis: regulating the regulators. Crit Rev Biochem Mol Biol , 2013, 48(1): 51-68. [13] Yu H, Duan BS, Jiang L, Lin M, Sheng HH, Huang JX, Gao HJ. Serum miR-200c and clinical outcome of patients with advanced esophageal squamous cancer receiving platinum-based chemotherapy. Am J Transl Res , 2013, 6(1): 71-77. [14] Badal SS, Danesh FR. MicroRNAs and their applications in kidney diseases. Pediatr Nephrol , 2014, doi:10.1007/s00467-014-2867-7. [15] Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, Downing JR, Jacks T, Horvitz HR, Golub TR. MicroRNA expression profiles classify human cancers. Nature , 2005, 435(7043): 834-838. [16] Ashby J, Flack K, Jimenez LA, Duan YK, Khatib AK, Somlo G, Wang SE, Cui X, Zhong W. Distribution profiling of circulating microRNAs in serum. Anal Chem , 2014, 86(18): 9343-9349. [17] Chen X, Ba Y, Ma LJ, Cai X, Yin Y, Wang KH, Guo JG, Zhang YJ, Chen JN, Guo X, Li QB, Li XY, Wang WJ, Zhang Y, Wang J, Jiang XY, Xiang Y, Xu C, Zheng PP, Zhang JB, Li RQ, Zhang HJ, Shang XB, Gong T, Ning G, Wang J, Zen K, Zhang JF, Zhang CY. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res , 2008, 18(10): 997-1006. [18] Lawrie CH, Gal S, Dunlop HM, Pushkaran B, Liggins AP, Pulford K, Banham AH, Pezzella F, Boultwood J, Wainscoat JS, Hatton CSR, Harris AL. Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br J Haematol , 2008, 141(5): 672-675. [19] Jarry J, Schadendorf D, Greenwood C, Spatz A, van Kempen LC. The validity of circulating microRNAs in oncology: five years of challenges and contradictions. Mol Oncol , 2014, 8(4): 819-829. [20] Komatsu S, Ichikawa D, Takeshita H, Morimura R, Hirajima S, Tsujiura M, Kawaguchi T, Miyamae M, Nagata H, Konishi H, Shiozaki A, Otsuji E. Circulating miR-18a: a sensitive cancer screening biomarker in human cancer. In Vivo , 2014, 28(3): 293-297. [21] Wu CY, Wang C, Guan XC, Liu YX, Li DM, Zhou XJ, Zhang YN, Chen X, Wang JJ, Zen K, Zhang CY, Zhang CN. Diagnostic and prognostic implications of a serum miRNA panel in oesophageal squamous cell carcinoma. PLoS One , 2014, 9(3): e92292. [22] Zou KH, O’Malley AJ, Mauri L. Receiver-operating characteristic analysis for evaluating diagnostic tests and predictive models. Circulation , 2007, 115(5): 654-657. [23] Hirajima S, Komatsu S, Ichikawa D, Takeshita H, Konishi H, Shiozaki A, Morimura R, Tsujiura M, Nagata H, Kawaguchi T, Arita T, Kubota T, Fujiwara H, Okamoto K, Otsuji E. Clinical impact of circulating miR-18a in plasma of patients with oesophageal squamous cell carcinoma. Br J Cancer , 2013, 108(9): 1822-1829. [24] Komatsu S, Ichikawa D, Hirajima S, Kawaguchi T, Miyamae M, Okajima W, Ohashi T, Arita T, Konishi H, Shiozaki A, Fujiwara H, Okamoto K, Yagi N, Otsuji E. Plasma microRNA profiles: identification of miR-25 as a novel diagnostic and monitoring biomarker in oesophageal squamous cell carcinoma. Br J Cancer , 2014, 111(8): 1614-1624. [25] Zhang TF, Wang QM, Zhao D, Cui YL, Cao BR, Guo LP, Lu SH. The oncogenetic role of microRNA-31 as a potential biomarker in oesophageal squamous cell carcinoma. Clin Sci , 2011, 121(10): 437-447. [26] Sharma P, Saraya A, Gupta P, Sharma R. Decreased levels of circulating and tissue miR-107 in human esophageal cancer. Biomarkers , 2013, 18(4): 322-330. [27] Liu R, Liao J, Yang M, Shi YJ, Peng Y, Wang Y, Pan EC, Guo W, Pu YP, Yin LH. Circulating miR-155 expression in plasma: a potential biomarker for early diagnosis of esophageal cancer in humans. J Toxicol Environ Health A , 2012, 75(18): 1154-1162. [28] 张燕妮, 李艳芳, 王成, 管晓翠, 陈熹, 曾科, 张辰宇, 张春妮. 食管鳞状细胞癌患者血清全基因组microRNA测序和分析. 临床检验杂志, 2012, 30(9): 641-644. [29] Takeshita N, Hoshino I, Mori M, Akutsu Y, Hanari N, Yoneyama Y, Ikeda N, Isozaki Y, Maruyama T, Akanuma N, Komatsu A, Jitsukawa M, Matsubara H. Serum microRNA expression profile: miR-1246 as a novel diagnostic and prognostic biomarker for oesophageal squamous cell carcinoma. Br J Cancer , 2013, 108(3): 644-652. [30] Zhang TF, Zhao D, Wang QM, Yu XY, Cui YL, Guo LP, Lu SH. MicroRNA-1322 regulates ECRG2 allele specifically and acts as a potential biomarker in patients with esophageal squamous cell carcinoma. Mol Carcinog , 2013, 52(8): 581-590. [31] Wang YY, Wang QX, Zhang N, Ma H, Gu YH, Tang HM, Xu ZG, Gao Y. Identification of microRNAs as novel biomarkers for detecting esophageal squamous cell carcinoma in Asians: a meta-analysis. Tumor Biol , 2014, 35(11): 11596-11604. [32] Kurashige J, Kamohara H, Watanabe M, Tanaka Y, Kinoshita K, Saito S, Hiyoshi Y, Iwatsuki M, Baba Y, Baba H. Serum microRNA-21 is a novel biomarker in patients with esophageal squamous cell carcinoma. J Surg Oncol , 2012, 106(2): 188-192. [33] 彭学宏, 陈暖, 李克, 郑邦希. 食管癌外周血miRNA的研究. 中国校医, 2013, 27(5): 353-355. [34] 曹波, 张红涛, 朱亚婷, 马媛媛. 新疆哈族食管癌血清microRNA初步筛查. 科技视界, 2014, (20): 62-63. [35] 彭学宏, 陈暖, 李克, 郑邦希. 实时荧光定量PCR检测食管癌循环miRNA的研究. 中国实用医刊, 2014, 41(6): 1-2. [36] Kroh EM, Parkin RK, Mitchell PS, Tewari M. Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). Methods , 2010, 50(4): 298-301. [37] Kirschner MB, Kao SC, Edelman JJ, Armstrong NJ, Vallely MP, van Zandwijk N, Reid G. Haemolysis during sample preparation alters microRNA content of plasma. PLoS One , 2011, 6(9): e24145. [38] Hunter MP, Ismail N, Zhang XL, Aguda BD, Lee EJ, Yu LB, Xiao T, Schafer J, Lee MLT, Schmittgen TD, Nana-Sinkam SP, Jarjoura D, Marsh CB. Detection of microRNA expression in human peripheral blood microvesicles. PLoS One , 2008, 3(11): e3694. [39] Tanaka Y, Kamohara H, Kinoshita K, Kurashige J, Ishimoto T, Iwatsuki M, Watanabe M, Baba H. Clinical impact of serum exosomal microRNA-21 as a clinical biomarker in human esophageal squamous cell carcinoma. Cancer , 2013, 119(6): 1159-1167. [40] Tanaka K, Miyata H, Yamasaki M, Sugimura K, Takahashi T, Kurokawa Y, Nakajima K, Takiguchi S, Mori M, Doki Y. Circulating miR-200c levels significantly predict response to chemotherapy and prognosis of patients undergoing neoadjuvant chemotherapy for esophageal cancer. Ann Surg Oncol , 2013, 20(S3): 607-615. |